Nadiia Kasianchuk

Ms. Nadiia Kasianchuk

Adam Mickiewicz University in Poznań, Poznań, Wielkopolskie, Poland
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2023 in Toxics
Verified
Journal Article
Open access
PDF file
Falfushynska HalinaFalfushynska Halina
Falfushynska Halina
NKNadiia Kasianchuk
Nadiia Kasianchuk
ESEduard Siemens
Eduard Siemens
EHEliana Henao
Eliana Henao
Piotr RzymskiPiotr Rzymski
Piotr Rzymski
Global warming and human-induced eutrophication drive the occurrence of various cyanotoxins in aquatic environments. These metabolites reveal diversified mechanisms of action, encompassing cyto-, neuro-, hepato-, nephro-, and neurotoxicity, and pose a threat to aquatic biota and human health. In the present paper, we review data on the occurrence of the most studied cyanotoxins, microcystins, nodularins, cylindrospermopsin, anatoxins, and saxitoxins, in the aquatic environment, as well as their potential bioaccumulation and toxicity in fish. Microcystins are the most studied among all known cyanotoxins, although other toxic cyanobacterial metabolites are also commonly identified in aquatic environments and can reveal high toxicity in fish. Except for primary toxicity signs, cyanotoxins adversely affect the antioxidant system and anti-/pro-oxidant balance. Cyanotoxins also negatively impact the mitochondrial and endoplasmic reticulum by increasing intracellular reactive oxygen species. Furthermore, fish exposed to microcystins and cylindrospermopsin exhibit various immunomodulatory, inflammatory, and endocrine responses. Even though cyanotoxins exert a complex pressure on fish, numerous aspects are yet to be the subject of in-depth investigation. Metabolites other than microcystins should be studied more thoroughly to understand the long-term effects in fish and provide a robust background for monitoring and management actions.

7 December 2022 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
NKNadiia Kasianchuk
Nadiia Kasianchuk
Piotr RzymskiPiotr Rzymski
Piotr Rzymski
ŁKŁukasz Kaczmarek
Łukasz Kaczmarek
Tardigrades are ubiquitous microinvertebrates exhibiting extreme tolerance to various environmental stressors like low and high temperatures, lack of water, or high radiation. Although exact pathways behind the tardigrade extremotolerance are yet to be elucidated, some molecules involved have been identified. Their evidenced properties may lead to novel opportunities in biomedical and pharmacological development. This review aims to present the general characteristics of tardigrade intrinsically disordered proteins (TDPs: Dsup, CAHS, SAHS, MAHS) and late embryogenesis-abundant proteins (LEA) and provide an updated overview of their features and relevance for potential use in biomedicine and pharmacology. The Dsup reveals a promising action in attenuating oxidative stress, DNA damage, and pyrimidine dimerization, as well as increasing radiotolerance in transfected human cells. Whether Dsup can perform these functions when delivered externally is yet to be understood by in vivo preclinical testing. In turn, CAHS and SAHS demonstrate properties that could benefit the preservation of pharmaceuticals (e.g., vaccines) and biomaterials (e.g., cells). Selected CAHS proteins can also serve as inspiration for designing novel anti-apoptotic agents. The LEA proteins also reveal promising properties to preserve desiccated biomaterials and can act as anti-osmotic agents. In summary, tardigrade molecules reveal several potential biomedical applications advocating further research and development. The challenge of extracting larger amounts of these molecules can be solved with genetic engineering and synthetic biology tools. With new species identified each year and ongoing studies on their extremotolerance, progress in the medical use of tardigrade proteins is expected shortly.

1 December 2019 in Science of The Total Environment
Verified
Journal Article
Closed access
HFHalina I. Falfushynska
Halina I. Falfushynska
FWFangli Wu
Fangli Wu
FYFei Ye
Fei Ye
NKNadiia Kasianchuk
Nadiia Kasianchuk
Joydeep DuttaJoydeep Dutta
Joydeep Dutta
Inna M. SokolovaInna M. Sokolova
Inna M. Sokolova

8 December 2023 in Viruses
Verified
Journal Article
Open access
PDF file
NKNadiia Kasianchuk
Nadiia Kasianchuk
Krystyna DobrowolskaKrystyna Dobrowolska
Krystyna Dobrowolska
SHSofiia Harkava
Sofiia Harkava
ABAndreea Bretcan
Andreea Bretcan
Dorota Zarębska-MichalukDorota Zarębska-Michaluk
Dorota Zarębska-Michaluk
Piotr RzymskiPiotr Rzymski
Piotr Rzymski
The hepatitis B virus (HBV) continues to cause substantial health and economic burdens, and its target of elimination may not be reached in 2030 without further efforts in diagnostics, non-pharmaceutical prevention measures, vaccination, and treatment. Current therapeutic options in chronic HBV, based on interferons and/or nucleos(t)ide analogs, suppress the virus replication but do not eliminate the pathogen and suffer from several constraints. This paper reviews the progress on biotechnological approaches in functional and definitive HBV treatments, including gene-editing tools, i.e., zinc-finger proteins, transcription activator-like effector nucleases, and CRISPR/Cas9, as well as therapeutics based on RNA interference. The advantages and challenges of these approaches are also discussed. Although the safety and efficacy of gene-editing tools in HBV therapies are yet to be demonstrated, they show promise for the revitalization of a much-needed advance in the field and offer viral eradication. Particular hopes are related to CRISPR/Cas9; however, therapeutics employing this system are yet to enter the clinical testing phases. In contrast, a number of candidates based on RNA interference, intending to confer a functional cure, have already been introduced to human studies. However, larger and longer trials are required to assess their efficacy and safety. Considering that prevention is always superior to treatment, it is essential to pursue global efforts in HBV vaccination.

12 January 2026 in Genome Biology
Verified
Journal Article
Open access
PDF file
VMViorel Munteanu
Viorel Munteanu
MSMichael A. Saldana
Michael A. Saldana
DDDavid Dreifuss
David Dreifuss
WOWenhao O. Ouyang
Wenhao O. Ouyang
JFJannatul Ferdous
Jannatul Ferdous
SMSerghei Mangul
Serghei Mangul
Wastewater-based genomic surveillance (WWGS) has proven effective for monitoring SARS-CoV-2 and other viruses within communities. It enables rapid detectio

22 April 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Falfushynska HalinaFalfushynska Halina
Falfushynska Halina
PRPiotr Rychter
Piotr Rychter
ABAnastasiia Boshtova
Anastasiia Boshtova
YFYuliia Faidiuk
Yuliia Faidiuk
NKNadiia Kasianchuk
Nadiia Kasianchuk
Piotr RzymskiPiotr Rzymski
Piotr Rzymski
The United Nations World Drug Report published in 2022 alarmed that the global market of illicit drugs is steadily expanding in space and scale. Substances of abuse are usually perceived in the light of threats to human health and public security, while the environmental aspects of their use and subsequent emissions usually remain less explored. However, as with other human activities, drug production, trade, and consumption of drugs may leave their environmental mark. Therefore, this paper aims to review the occurrence of illicit drugs in surface waters and their bioaccumulation and toxicity in fish. Illicit drugs of different groups, i.e., psychostimulants (methamphetamines/amphetamines, cocaine, and its metabolite benzoylecgonine) and depressants (opioids: morphine, heroin, methadone, fentanyl), can reach the aquatic environment through wastewater discharge as they are often not entirely removed during wastewater treatment processes, resulting in their subsequent circulation in nanomolar concentrations, potentially affecting aquatic biota, including fish. Exposure to such xenobiotics can induce oxidative stress and dysfunction to mitochondrial and lysosomal function, distort locomotion activity by regulating the dopaminergic and glutamatergic systems, increase the predation risk, instigate neurological disorders, disbalance neurotransmission, and produce histopathological alterations in the brain and liver tissues, similar to those described in mammals. Hence, this drugs-related multidimensional harm to fish should be thoroughly investigated in line with environmental protection policies before it is too late. At the same time, selected fish species (e.g., Danio rerio, zebrafish) can be employed as models to study toxic and binge-like effects of psychoactive, illicit compounds.